Robert M. Centor, MD; Chad Burski, MD
Disclosures: Dr. Centor has disclosed the following: Honoraria: Medscape. Dr. Burski has disclosed the following: Research Grants/Contracts: Cook, Takeda. Stock options/holdings: Merck, Johnson & Johnson, AstraZeneca.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose.
Audio. Annals On Call - Approach to UGI Bleeding: In this episode, Dr. Centor discusses the approach to patients with upper gastrointestinal bleeding with Dr. Chad Burski.
Other Audio Options: Download MP3
Centor RM, Burski C. Annals On Call - Approach to UGI Bleeding. Ann Intern Med. 2020;172:OC1. doi: https://doi.org/10.7326/A19-0021
Download citation file:
Published: Ann Intern Med. 2020;172(1):OC1.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use